BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/18/2025 7:43:21 AM | Browse: 22 | Download: 34
 |
Received |
|
2024-12-28 10:25 |
|
Peer-Review Started |
|
2024-12-28 10:25 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-02-20 02:41 |
|
Revised |
|
2025-02-27 01:56 |
|
Second Decision |
|
2025-03-13 02:33 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-03-13 03:09 |
|
Articles in Press |
|
2025-03-13 03:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2025-03-18 00:17 |
|
Typeset the Manuscript |
|
2025-04-14 03:04 |
|
Publish the Manuscript Online |
|
2025-04-18 07:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Rethinking carnitine palmitoyltransferase-II and liver stem cells in metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hong Cai, Chun-Hui Yang and Peng Gao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Peng Gao, PhD, Professor, Department of Clinical Laboratory, The Second Hospital of Dalian Medical University, No. 467 Zhongshan Road, Dalian 116023, Liaoning Province, China. gaop@dmu.edu.cn |
| Key Words |
Metabolic dysfunction-associated fatty liver disease; Carnitine palmitoyltransferase-II; Hepatocellular carcinoma; Liver cancer stem cells; Mitochondrial dysfunction; Metabolic dysfunction |
| Core Tip |
This article reviews a recent study by Wang et al investigating how carnitine palmitoyltransferase-II inactivity drives malignant progression in metabolic dysfunction-associated fatty liver disease through aberrant lipid metabolism, T-cell dysfunction, and liver cancer stem cells activation. Their work revealed that mitochondrial damage and reduced carnitine palmitoyltransferase-II activity under lipid-rich conditions may be early indicators of liver cancer risk, influencing immune cell profiles and the stem cell-like properties of hepatocytes. Understanding these processes could pave the way for novel preventative and therapeutic interventions targeting the metabolic and immunological underpinnings of metabolic dysfunction-associated fatty liver disease-related hepatocarcinogenesis. |
| Publish Date |
2025-04-18 07:43 |
| Citation |
<p>Cai H, Yang CH, Gao P. Rethinking carnitine palmitoyltransferase-II and liver stem cells in metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma. <i>World J Gastroenterol</i> 2025; 31(15): 104528</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i15/104528.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i15.104528 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
